🇺🇸 FDA
Patent

US 10934363

Chimeric antigen receptors based on single domain antibodies and methods of use thereof

granted A61KA61K2239/29A61K2239/48

Quick answer

US patent 10934363 (Chimeric antigen receptors based on single domain antibodies and methods of use thereof) held by LEGEND BIOTECH USA INC. expires Mon Feb 25 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
LEGEND BIOTECH USA INC.
Grant date
Tue Mar 02 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Feb 25 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
24
CPC classes
A61K, A61K2239/29, A61K2239/48, A61K40/11, A61K40/31